Skip to main content
Top
Published in: Digestive Diseases and Sciences 2/2014

Open Access 01-02-2014 | Original Article

Translation and Psychometric Evaluation of the Chinese Version of Functional Digestive Disorders Quality of Life Questionnaire

Authors: Liu Feng-bin, Jin Yong-xing, Wu Yu-hang, Hou Zheng-kun, Chen Xin-lin

Published in: Digestive Diseases and Sciences | Issue 2/2014

Login to get access

Abstract

Background

Few useful patient-reported outcomes scales for functional dyspepsia exist in China.

Aims

The purpose of this work was to translate and cross-culturally adapt the Functional Digestive Disorders Quality of Life Questionnaire (FDDQL) from the English version to Chinese (in Mandarin).

Methods

The following steps were performed: forward translations, synthesis of the translations, backward translations, pre-testing and field testing of FDDQL. Reliability, validity, responsiveness, confirmatory factor analysis, item response theory and differential item functioning of the scale were analyzed.

Results

A total of 300 functional dyspepsia patients and 100 healthy people were included. The total Cronbach’s alpha was 0.932, and split-half reliability coefficient was 0.823 with all test–retest coefficients greater than 0.9 except Coping With Disease domain. In construct validity analysis, every item correlated higher with its own domain than others. The comparative fit index of FDDQL was 0.902 and root mean square error of approximation was 0.076. Functional dyspepsia patients and healthy people had significant differences in all domains. After treatment, all domains had significant improvements except diet. Item response theory analysis showed the Person separation index of 0.920 and the threshold estimator of items was normally distributed with a mean of 0 and standard deviation of 1.27. The residuals of each item were between −2.5 and 2.5, without statistical significance. Differential item functioning analysis found that items had neither uniform nor non-uniform differential item functioning in different genders and age groups.

Conclusions

The Chinese version of FDDQL has good psychometric properties and is suitable for measuring the health status of Chinese patients with functional dyspepsia.
Appendix
Available only for authorised users
Literature
1.
go back to reference Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130:1466–1479.PubMedCrossRef Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130:1466–1479.PubMedCrossRef
2.
go back to reference Mahadeva S, Goh KL. Epidemiology of functional dyspepsia: a global perspective. World J Gastroenterol. 2006;12:2661–2666.PubMed Mahadeva S, Goh KL. Epidemiology of functional dyspepsia: a global perspective. World J Gastroenterol. 2006;12:2661–2666.PubMed
3.
go back to reference Shaib Y, El-Serag HB. The prevalence and risk factors of functional dyspepsia in a multiethnic population in the United States. Am J Gastroenterol.. 2004;99:2210–2216.PubMedCrossRef Shaib Y, El-Serag HB. The prevalence and risk factors of functional dyspepsia in a multiethnic population in the United States. Am J Gastroenterol.. 2004;99:2210–2216.PubMedCrossRef
5.
go back to reference Agreus L, Borgquist L. The cost of gastro-oesophageal reflux disease, dyspepsia and peptic ulcer disease in Sweden. Pharmacoeconomics. 2002;20:347–355.PubMedCrossRef Agreus L, Borgquist L. The cost of gastro-oesophageal reflux disease, dyspepsia and peptic ulcer disease in Sweden. Pharmacoeconomics. 2002;20:347–355.PubMedCrossRef
6.
go back to reference Martin C, Marquis P, Bonfils S. A quality of life questionnaire adapted to duodenal ulcer therapeutic trials. Scand J Gastroenterolgy. 1994;206:40.CrossRef Martin C, Marquis P, Bonfils S. A quality of life questionnaire adapted to duodenal ulcer therapeutic trials. Scand J Gastroenterolgy. 1994;206:40.CrossRef
7.
go back to reference Wiklund IK, Junghard O, Grace E, et al. Quality of life in reflux and dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl. 1998;583:41–49.PubMed Wiklund IK, Junghard O, Grace E, et al. Quality of life in reflux and dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl. 1998;583:41–49.PubMed
8.
go back to reference Chassany O, Marquis P, Scherrer B, et al. Validation of a specific quality of life questionnaire for functional digestive disorders. Gut. 1999;44:527–533.PubMedCrossRef Chassany O, Marquis P, Scherrer B, et al. Validation of a specific quality of life questionnaire for functional digestive disorders. Gut. 1999;44:527–533.PubMedCrossRef
9.
go back to reference Chassany O, Bergmann JF. Quality of life in irritable bowel syndrome, effect of therapy. Eur J Surg Suppl. 1998;583:81–86.PubMed Chassany O, Bergmann JF. Quality of life in irritable bowel syndrome, effect of therapy. Eur J Surg Suppl. 1998;583:81–86.PubMed
10.
go back to reference Bamfi F, Olivieri A, Arpinelli F, et al. Measuring quality of life in dyspeptic patients: development and validation of a new specific health status questionnaire: final report from the Italian QPD project involving 4000 patients. Am J Gastroenterol. 1999;94:730–738.PubMed Bamfi F, Olivieri A, Arpinelli F, et al. Measuring quality of life in dyspeptic patients: development and validation of a new specific health status questionnaire: final report from the Italian QPD project involving 4000 patients. Am J Gastroenterol. 1999;94:730–738.PubMed
11.
go back to reference Talley NJ, Haque M, Wyeth JW, et al. Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index. Aliment Pharmacol Ther. 1999;13:225–235.PubMedCrossRef Talley NJ, Haque M, Wyeth JW, et al. Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index. Aliment Pharmacol Ther. 1999;13:225–235.PubMedCrossRef
12.
go back to reference Rabeneck L, Cook KF, Wristers K, Souchek J, Menke T, Wray NP. SODA (severity of dyspepsia assessment): a new effective outcome measure for dyspepsia-related health. J Clin Epidemiol. 2001;54:755–765.PubMedCrossRef Rabeneck L, Cook KF, Wristers K, Souchek J, Menke T, Wray NP. SODA (severity of dyspepsia assessment): a new effective outcome measure for dyspepsia-related health. J Clin Epidemiol. 2001;54:755–765.PubMedCrossRef
13.
go back to reference Min-hu C, Bi-hui Z, Chu-jun L, Xiao-zhong P, Pin-jin H. An Epidemiological study on dyspepsia in Guangdong area. Chin J Intern Med. 1998;37:312–314. Min-hu C, Bi-hui Z, Chu-jun L, Xiao-zhong P, Pin-jin H. An Epidemiological study on dyspepsia in Guangdong area. Chin J Intern Med. 1998;37:312–314.
14.
go back to reference Buzas GM. Assessment of quality of life in functional dyspepsia. Validation of a questionnaire and its use in clinical practice. Orv Hetil. 2004;145:687–692.PubMed Buzas GM. Assessment of quality of life in functional dyspepsia. Validation of a questionnaire and its use in clinical practice. Orv Hetil. 2004;145:687–692.PubMed
15.
go back to reference Sabate JM, Veyrac M, Mion F, et al. Relationship between rectal sensitivity, symptoms intensity and quality of life in patients with irritable bowel syndrome. Aliment Pharmacol Ther. 2008;28:484–490.PubMedCentralPubMedCrossRef Sabate JM, Veyrac M, Mion F, et al. Relationship between rectal sensitivity, symptoms intensity and quality of life in patients with irritable bowel syndrome. Aliment Pharmacol Ther. 2008;28:484–490.PubMedCentralPubMedCrossRef
16.
go back to reference Schneider A, Weiland C, Enck P, et al. Neuroendocrinological effects of acupuncture treatment in patients with irritable bowel syndrome. Complement Ther Med. 2007;15:255–263.PubMedCrossRef Schneider A, Weiland C, Enck P, et al. Neuroendocrinological effects of acupuncture treatment in patients with irritable bowel syndrome. Complement Ther Med. 2007;15:255–263.PubMedCrossRef
17.
go back to reference Schneider A, Enck P, Streitberger K, et al. Acupuncture treatment in irritable bowel syndrome. Gut. 2006;55:649–654.PubMedCrossRef Schneider A, Enck P, Streitberger K, et al. Acupuncture treatment in irritable bowel syndrome. Gut. 2006;55:649–654.PubMedCrossRef
18.
go back to reference Huang YD. Development and evaluation of the chronic gastritis subscale in gastroenteric disease PRO scale (SSDPRO-CG). Guangzhou: Guangzhou University of Chinese Medicine; 2009. Huang YD. Development and evaluation of the chronic gastritis subscale in gastroenteric disease PRO scale (SSDPRO-CG). Guangzhou: Guangzhou University of Chinese Medicine; 2009.
19.
go back to reference Brown GTL, Glasswell K, Harland D. Accuracy in the scoring of writing: studies of reliability and validity using a new zeal and writing assessment system. Assess Writi. 2004;9:105–121.CrossRef Brown GTL, Glasswell K, Harland D. Accuracy in the scoring of writing: studies of reliability and validity using a new zeal and writing assessment system. Assess Writi. 2004;9:105–121.CrossRef
20.
go back to reference Cheung GW, Rensvold RB. Evaluating goodness-of-fit indexes for testing measurement invariance. Struct Equ Model. 2002;9:233–255.CrossRef Cheung GW, Rensvold RB. Evaluating goodness-of-fit indexes for testing measurement invariance. Struct Equ Model. 2002;9:233–255.CrossRef
21.
go back to reference Rasch G. Studies in mathematical psychology: probabilistic models for some intelligence and attainment tests. Denmark: Danish Institute for Educational Research; 1960. Rasch G. Studies in mathematical psychology: probabilistic models for some intelligence and attainment tests. Denmark: Danish Institute for Educational Research; 1960.
22.
go back to reference Masters GN. A Rasch model for partial credit scoring. Psychometrika. 1982;47:149–174.CrossRef Masters GN. A Rasch model for partial credit scoring. Psychometrika. 1982;47:149–174.CrossRef
23.
go back to reference Joreskog KG, Sorbom D. LISREL 8.7 for Windows [computer software]. Lincolnwood, IL: Scientific Software International; 2004. Joreskog KG, Sorbom D. LISREL 8.7 for Windows [computer software]. Lincolnwood, IL: Scientific Software International; 2004.
24.
go back to reference Andrich, D. Rasch unidimensional measurement models (RUMM) 2020 (Version 4.0). Perth: Rumm Laboratory Pty Ltd; 2003. Andrich, D. Rasch unidimensional measurement models (RUMM) 2020 (Version 4.0). Perth: Rumm Laboratory Pty Ltd; 2003.
25.
go back to reference Buzás GM. Quality of life in patients with functional dyspepsia: short- and long-term effect of Helicobacter pylori eradication with pantoprazole, amoxicillin, and clarithromycin or cisapride therapy: a prospective, parallel-group study. Curr Ther Res. 2006;67:305–320.CrossRef Buzás GM. Quality of life in patients with functional dyspepsia: short- and long-term effect of Helicobacter pylori eradication with pantoprazole, amoxicillin, and clarithromycin or cisapride therapy: a prospective, parallel-group study. Curr Ther Res. 2006;67:305–320.CrossRef
Metadata
Title
Translation and Psychometric Evaluation of the Chinese Version of Functional Digestive Disorders Quality of Life Questionnaire
Authors
Liu Feng-bin
Jin Yong-xing
Wu Yu-hang
Hou Zheng-kun
Chen Xin-lin
Publication date
01-02-2014
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 2/2014
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-013-2897-1

Other articles of this Issue 2/2014

Digestive Diseases and Sciences 2/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine